Interpharm Holdings, Inc. IPAH

IPAH Company Overview

Interpharm Holdings, Inc. (formerly traded on NASDAQ under the ticker IPAH) was a U.S.-based pharmaceutical company focused primarily on the development, manufacture, and distribution of generic prescription and over-the-counter pharmaceutical products. The company operated within the generic drug manufacturing and specialty pharmaceutical industries, supplying products to wholesalers, distributors, chain pharmacies, and healthcare providers across the United States. Its revenue was primarily generated through sales of solid oral dosage generic pharmaceuticals, including tablets and capsules produced for both proprietary and contract manufacturing customers.

The company built its business around vertically integrated pharmaceutical manufacturing capabilities and regulatory compliance expertise tied to U.S. Food and Drug Administration approval processes. Interpharm expanded through acquisitions and product portfolio development during the early 2000s, positioning itself as a growing participant in the U.S. generic drug market. In 2007, Watson Pharmaceuticals, Inc. acquired Interpharm Holdings, Inc., after which the company ceased operating as an independent public entity. Public information following the acquisition became limited because the company was integrated into Watson’s broader generic pharmaceutical operations.